» Articles » PMID: 31217224

Cigarette Consumption Estimates for 71 Countries from 1970 to 2015: Systematic Collection of Comparable Data to Facilitate Quasi-experimental Evaluations of National and Global Tobacco Control Interventions

Abstract

Objectives: To collect, appraise, select, and report the best available national estimates of cigarette consumption since 1970.

Design: Systematic collection of comparable data.

Setting And Population: 71 of 214 countries for which searches for national cigarette consumption data were conducted, representing over 95% of global cigarette consumption and 85% of the world's population.

Main Outcome Measures: Validated cigarette consumption data covering 1970-2015 were identified for 71 countries. Data quality appraisal was conducted by two research team members in duplicate, with greatest weight given to official government sources. All data were standardised into units of cigarettes consumed per year in each country, a detailed accounting of data quality and sourcing was prepared, and all collected data and metadata were made freely available in an open access dataset.

Results: Cigarette consumption fell in most countries over the past three decades but trends in country specific consumption were highly variable. For example, China consumed 2.5 million metric tonnes (MMT) of cigarettes in 2013, more than Russia (0.36 MMT), the United States (0.28 MMT), Indonesia (0.28 MMT), Japan (0.20 MMT), and the next 35 highest consuming countries combined. The US and Japan achieved reductions of more than 0.1 MMT from a decade earlier, whereas Russian consumption plateaued, and Chinese and Indonesian consumption increased by 0.75 MMT and 0.1 MMT, respectively. These data generally concord with modelled country level data from the Institute for Health Metrics and Evaluation and have the additional advantage of not smoothing year-over-year discontinuities that are necessary for robust quasi-experimental impact evaluations.

Conclusions: Before this study, publicly available data on cigarette consumption have been limited; they have been inappropriate for quasi-experimental impact evaluations (modelled data), held privately by companies (proprietary data), or widely dispersed across many national statistical agencies and research organisations (disaggregated data). This new dataset confirms that cigarette consumption has decreased in most countries over the past three decades, but that secular country specific consumption trends are highly variable. The findings underscore the need for more robust processes in data reporting, ideally built into international legal instruments or other mandated processes. To monitor the impact of the WHO Framework Convention on Tobacco Control and other tobacco control interventions, data on national tobacco production, trade, and sales should be routinely collected and openly reported.

Citing Articles

The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035.

Wang Y, Zhu J, Wang S, Zhou J Front Oncol. 2025; 14():1511530.

PMID: 39830644 PMC: 11739153. DOI: 10.3389/fonc.2024.1511530.


The burden of Gastric Cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the Global Burden of Disease Study 2021.

Qin N, Fan Y, Yang T, Yang Z, Fan D Biomark Res. 2025; 13(1):5.

PMID: 39773334 PMC: 11708091. DOI: 10.1186/s40364-024-00720-8.


Is there a link between per capita alcohol consumption and cancer mortality?.

Dadgar I, Norstrom T, Ramstedt M Drug Alcohol Rev. 2024; 44(2):411-423.

PMID: 39667722 PMC: 11814354. DOI: 10.1111/dar.13984.


Associations of Sedentary Behavior with Risks of Cardiovascular Disease Events among Chinese Adults.

Ling Y, Tao Z, Wan Y, Cui H, Zhang Z, Pei J J Atheroscler Thromb. 2024; 31(10):1398-1415.

PMID: 38569881 PMC: 11456351. DOI: 10.5551/jat.64760.


Changing profiles of the burden of Alzheimer's disease and other dementias attributable to smoking in the belt and road initiative countries: A secondary analysis of global burden of disease 2019.

Luo Z, He X, Lv H, Wang Q, Jia W, Zhao Y Heliyon. 2024; 10(6):e27935.

PMID: 38515688 PMC: 10955296. DOI: 10.1016/j.heliyon.2024.e27935.


References
1.
Reda A, Kotz D, Evers S, van Schayck C . Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2012; (6):CD004305. DOI: 10.1002/14651858.CD004305.pub4. View

2.
Martinez C, Martinez-Sanchez J, Robinson G, Bethke C, Fernandez E . Protection from secondhand smoke in countries belonging to the WHO European Region: an assessment of legislation. Tob Control. 2013; 23(5):403-11. DOI: 10.1136/tobaccocontrol-2012-050715. View

3.
Hamilton F, Greaves F, Majeed A, Millett C . Effectiveness of providing financial incentives to healthcare professionals for smoking cessation activities: systematic review. Tob Control. 2011; 22(1):3-8. DOI: 10.1136/tobaccocontrol-2011-050048. View

4.
Hammond D . Health warning messages on tobacco products: a review. Tob Control. 2011; 20(5):327-37. DOI: 10.1136/tc.2010.037630. View

5.
McNeill A, Hammond D, Gartner C . Whither tobacco product regulation?. Tob Control. 2012; 21(2):221-6. DOI: 10.1136/tobaccocontrol-2011-050258. View